Three major Indian pharma companies launched their own versions of the drug. A new range of lower cost semaglutide injections has been launched in India, offering fresh hope to people living with type ...
Hosted on MSN
Lupin, Zydus to co-market weight loss, diabetes injection in India; check stocks' reaction
Shares of Lupin and Zydus Lifesciences rose up to 2% on Tuesday after the pharma firm inked a licensing and supply agreement with the lifesciences company, to expand access to innovative Semaglutide ...
Robert Bosch LLC beat Westport Fuel Systems Canada Inc.’s patent infringement allegations over the manufacturing of fuel-injection valves sold to automakers. A Bosch spokesperson said in an email the ...
Valve Says New Steam Machine, Controller, and Frame Will Still Land in 2026 Despite a pessimistic sounding now-deleted blog post highlighting challenges caused by the current memory shortage, Valve ...
A day after Novo Nordisk's patent expiry, three Indian pharma companies - Sun Pharma, Zydus Lifesciences, and Dr. Reddy's Laboratories - have come out with a generic version of the semaglutide ...
National Institute for Health and Care Excellence (NICE) recommends tirzepatide (Mounjaro®) for the management of obesity for certain patients. Tirzepatide (also called Mounjaro ®) is a weight loss ...
Natco Pharma Ltd launched its generic semaglutide injection in India on Friday, March 20, with prices starting at ₹1,290 per month, positioning it as a significantly more affordable option. The move ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results